Doesn’t LL have the power to do a lot of good to CRC patients on its own besides this PD-L1 Escalation and checkpoint inhibitor business? I used to think it did.
(4)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
